These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 12664314)

  • 1. Polymorphisms of the gene encoding the inflammatory cytokine interleukin-6 determine the magnitude of the increase in soluble interleukin-6 receptor levels in Alzheimer's disease. Results of a pilot study.
    Bagli M; Papassotiropoulos A; Hampel H; Becker K; Jessen F; Bürger K; Ptok U; Rao ML; Möller HJ; Maier W; Heun R
    Eur Arch Psychiatry Clin Neurosci; 2003 Feb; 253(1):44-8. PubMed ID: 12664314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of IL-6 polymorphism on risk of Alzheimer disease: genotype-phenotype association study in Japanese cases.
    Shibata N; Ohnuma T; Takahashi T; Baba H; Ishizuka T; Ohtsuka M; Ueki A; Nagao M; Arai H
    Am J Med Genet; 2002 May; 114(4):436-9. PubMed ID: 11992567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of plasma IL-6 and soluble IL-6 receptor levels with the Asp358Ala polymorphism of the IL-6 receptor gene in schizophrenic patients.
    Sasayama D; Wakabayashi C; Hori H; Teraishi T; Hattori K; Ota M; Ishikawa M; Arima K; Higuchi T; Amano N; Kunugi H
    J Psychiatr Res; 2011 Nov; 45(11):1439-44. PubMed ID: 21700295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-6 and sIL-6R concentration in the cerebrospinal fluid and serum of MS patients.
    Stelmasiak Z; Kozioł-Montewka M; Dobosz B; Rejdak K
    Med Sci Monit; 2001; 7(5):914-8. PubMed ID: 11535934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-6 signalling in juvenile idiopathic arthritis is limited by proteolytically cleaved soluble interleukin-6 receptor.
    Peake NJ; Khawaja K; Myers A; Nowell MA; Jones SA; Rowan AD; Cawston TE; Foster HE
    Rheumatology (Oxford); 2006 Dec; 45(12):1485-9. PubMed ID: 16690760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of soluble interleukin 6 receptor in cerebrospinal fluid in inflammatory and non-inflammatory conditions.
    Azuma H; Moriyama T; Ikeda H; Oshima M; Okuno A; Sekiguchi S
    Cytokine; 2000 Feb; 12(2):160-4. PubMed ID: 10671302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin 6-174 G/C promoter gene polymorphism and sporadic Alzheimer's disease: geographic allele and genotype variations in Europe.
    Capurso C; Solfrizzi V; D'Introno A; Colacicco AM; Capurso SA; Capurso A; Panza F
    Exp Gerontol; 2004 Oct; 39(10):1567-73. PubMed ID: 15501028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble interleukin-6 receptor (sIL-6R) in cerebrospinal fluid of patients with inflammatory and non inflammatory neurological diseases.
    Michalopoulou M; Nikolaou C; Tavernarakis A; Alexandri NM; Rentzos M; Chatzipanagiotou S; Cambouri C; Vassilopoulos D
    Immunol Lett; 2004 Jul; 94(3):183-9. PubMed ID: 15275965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms in the IL-6 receptor (IL-6R) gene: strong evidence that serum levels of soluble IL-6R are genetically influenced.
    Galicia JC; Tai H; Komatsu Y; Shimada Y; Akazawa K; Yoshie H
    Genes Immun; 2004 Sep; 5(6):513-6. PubMed ID: 15306846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble interleukin 6 receptor: A novel marker of moderate to severe sleep-related breathing disorder.
    Mehra R; Storfer-Isser A; Kirchner HL; Johnson N; Jenny N; Tracy RP; Redline S
    Arch Intern Med; 2006 Sep; 166(16):1725-31. PubMed ID: 16983050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble IL-6 receptor potentiates the antagonistic activity of soluble gp130 on IL-6 responses.
    Müller-Newen G; Küster A; Hemmann U; Keul R; Horsten U; Martens A; Graeve L; Wijdenes J; Heinrich PC
    J Immunol; 1998 Dec; 161(11):6347-55. PubMed ID: 9834125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-6 receptor signaling. II. Bio-availability of interleukin-6 in serum.
    Gaillard J; Pugnière M; Tresca J; Mani J; Klein B; Brochier J
    Eur Cytokine Netw; 1999 Sep; 10(3):337-44. PubMed ID: 10477390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-6 receptor signaling. I. gp80 and gp130 receptor interaction in the absence of interleukin-6.
    Gaillard JP; Mani JC; Liautard J; Klein B; Brochier J
    Eur Cytokine Netw; 1999 Mar; 10(1):43-8. PubMed ID: 10210772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble cytokine receptors in renal vasculitis and lupus nephritis.
    Tesar V; Jirsa M; Zima T; Kalousová M; Bartunková J; Stejskalová A; Dostál C; Zabka J
    Med Sci Monit; 2002 Jan; 8(1):BR24-9. PubMed ID: 11782670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between circulating interleukin-10 (IL-10) with interleukin-6 (IL-6) type cytokines (IL-6, interleukin-11 (IL-11), oncostatin M (OSM)) and soluble interleukin-6 (IL-6) receptor (sIL-6R) in patients with multiple myeloma.
    Urbańska-Ryś H; Wiersbowska A; Stepień H; Robak T
    Eur Cytokine Netw; 2000 Sep; 11(3):443-51. PubMed ID: 11022130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of omega-3 fatty acids on inflammatory markers in cerebrospinal fluid and plasma in Alzheimer's disease: the OmegAD study.
    Freund-Levi Y; Hjorth E; Lindberg C; Cederholm T; Faxen-Irving G; Vedin I; Palmblad J; Wahlund LO; Schultzberg M; Basun H; Eriksdotter Jönhagen M
    Dement Geriatr Cogn Disord; 2009; 27(5):481-90. PubMed ID: 19439966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble interleukin-1 receptor type II, IL-18 and caspase-1 in mild cognitive impairment and severe Alzheimer's disease.
    Lindberg C; Chromek M; Ahrengart L; Brauner A; Schultzberg M; Garlind A
    Neurochem Int; 2005 Jun; 46(7):551-7. PubMed ID: 15843049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased levels of plasma interleukin-6 soluble receptor in patients with essential thrombocythemia.
    Marta R; Goette N; Lev P; Heller P; Kornblihtt L; Vassallú P; Glembotsky A; Pirola C; Molinas F
    Haematologica; 2004 Jun; 89(6):657-63. PubMed ID: 15194532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum levels of interleukin 6 (IL-6), oncostatin M, soluble IL-6 receptor, and soluble gp130 in patients with systemic sclerosis.
    Hasegawa M; Sato S; Fujimoto M; Ihn H; Kikuchi K; Takehara K
    J Rheumatol; 1998 Feb; 25(2):308-13. PubMed ID: 9489824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic value of soluble interleukin-6 receptor in patients with multiple myeloma.
    Stasi R; Brunetti M; Parma A; Di Giulio C; Terzoli E; Pagano A
    Cancer; 1998 May; 82(10):1860-6. PubMed ID: 9587117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.